A Phase II Randomised, Double-Blind, Placebo Controlled, Cross-Over Study to Investigate the Efficacy of Mexiletine in Patients with Non-Dystrophic Myotonia. [IMPIEGO DELLA MEXILETINA NELLE MIOTONIE NON DISTROFICHE: SPERIMENTAZIONE CLINICA DI FASE II (IND # 77,021)]

Trial Profile

A Phase II Randomised, Double-Blind, Placebo Controlled, Cross-Over Study to Investigate the Efficacy of Mexiletine in Patients with Non-Dystrophic Myotonia. [IMPIEGO DELLA MEXILETINA NELLE MIOTONIE NON DISTROFICHE: SPERIMENTAZIONE CLINICA DI FASE II (IND # 77,021)]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2013

At a glance

  • Drugs Mexiletine (Primary)
  • Indications Myotonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jul 2012 Additional trial location added as reported by European Clinical Trials Database.
    • 08 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top